Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/11/2025

Treatment of Gaseous Distention of the Large Bowel

Initial Diagnostic and Therapeutic Approach

  • The American Gastroenterological Association recommends a 2-week dietary elimination trial targeting FODMAPs, lactose, and fructose, as this addresses the most common causes and provides both diagnostic and therapeutic benefit in the majority of patients 1, 2
  • Fructose intolerance affects approximately 60% of patients with digestive disorders, making it the most prevalent carbohydrate malabsorption, followed by lactose intolerance at 51% 2, 3
  • In patients who respond to dietary restriction (>80% improvement at 1 month), dietary restriction led to complete symptom resolution in 50% at 1 year 1
  • The American Gastroenterological Association advises against long-term strict FODMAP restriction due to potential negative impacts on gut microbiome and risk of malnutrition; plan for systematic reintroduction after initial restriction 4

Pharmacological Treatment Options

  • Lubiprostone, linaclotide, or plecanatide are superior to placebo for treating abdominal bloating and distention, particularly when constipation coexists 2, 3
  • These agents improve both bloating symptoms and quality of life through enhanced intestinal secretion and transit 1
  • Rifaximin 550 mg three times daily for 14 days is the most studied antibiotic for SIBO and IBS-D with bloating 3
  • High-risk patients warranting empiric treatment or testing include those with chronic watery diarrhea, malnutrition, weight loss, cystic fibrosis, or Parkinson disease 5

Non-Pharmacological Interventions

  • Diaphragmatic breathing techniques provide immediate relief by reducing vagal tone and sympathetic activity, correcting the paradoxical diaphragmatic contraction seen in abdominophrenic dyssynergia 2, 3
  • Cognitive behavioral therapy (CBT) and gut-directed hypnotherapy have robust evidence for improving bloating symptoms and quality of life 2, 3

Evaluation for Underlying Structural Causes

  • Evaluate for dyssynergic defecation in patients with constipation and bloating, especially those reporting straining with soft stool, digital disimpaction, or splinting 4
  • Digital rectal examination identifies increased/decreased sphincter tone, pelvic floor dyssynergia, rectal prolapse, anal stricture, or rectocele 4
  • Confirm pelvic floor dyssynergia with anorectal physiology testing combined with balloon expulsion, particularly in women with IBS-C not responding to standard therapies 4

Special Diagnostic Considerations

  • Screen with tissue transglutaminase IgA and total IgA levels in patients with bloating, especially with weight loss, iron-deficiency anemia, or direct symptom association with gluten ingestion 5
  • Small bowel biopsy confirms diagnosis if serology is positive before initiating gluten-free diet 5
  • Recent evidence suggests fructans rather than gluten may cause symptoms in nonceliac gluten sensitivity; consider fructan elimination only 5, 4

Common Pitfalls to Avoid

  • Do not use opioid analgesics for chronic abdominal pain, as they further delay gastric emptying and worsen gas symptoms 3
  • Avoid promoting unscrupulous fad diets or herbal therapies propagated through social media, which can lead to malnutrition or toxicity 1
  • PPIs have limited effectiveness for bloating unless directly associated with GERD and should not be used as first-line treatment for isolated bloating 6